Table 2 Discontinuation of sorafenib in the non-intervention group (n = 7)
Adverse drug reactions (Grade) | Daily dose (mg) | Diagnosis | Previous therapy |
|---|---|---|---|
Hand-foot skin reaction (3) | 800 | hepatocellular carcinoma | TACE, RFA, Operation |
Hand-foot skin reaction (3) | 800 | renal cell carcinoma | Interleukin |
Hand-foot skin reaction (2) | 800 | renal cell carcinoma | Interferon, Sunitiniba |
Hand-foot skin reaction (3) | 200 | hepatocellular carcinoma | TACE, RFA |
Anorexia (2) | 400 | renal cell carcinoma | None |
Hypothyroidism (2) | 600 | renal cell carcinoma | Surgery |
Diarrhea (1) | 800 | hepatocellular carcinoma | TACE, RFA |